OTC Markets OTCPK - Delayed Quote USD
EssilorLuxottica Société anonyme (ESLOF)
289.75
0.00
(0.00%)
At close: May 27 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 15 | 17 |
Avg. Estimate | 7.29B | 6.8B | 27.98B | 29.88B |
Low Estimate | 7.29B | 6.8B | 27.35B | 29.02B |
High Estimate | 7.29B | 6.8B | 28.43B | 31.6B |
Year Ago Sales | 6.96B | 6.44B | 26.51B | 27.98B |
Sales Growth (year/est) | 4.74% | 5.59% | 5.55% | 6.81% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ESLOF | -- | -- | -- | -- |
S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Related Tickers
3600.HK Modern Dental Group Limited
4.070
+1.50%
INFU InfuSystem Holdings, Inc.
5.78
+3.21%
LMAT LeMaitre Vascular, Inc.
82.20
+1.39%
STAA STAAR Surgical Company
17.81
-2.84%
TFX Teleflex Incorporated
122.27
-0.21%
RMD ResMed Inc.
244.79
-0.13%
EKSO Ekso Bionics Holdings, Inc.
0.3020
-0.23%
WST West Pharmaceutical Services, Inc.
210.85
+0.19%
ALGN Align Technology, Inc.
180.94
-1.15%
HBIO Harvard Bioscience, Inc.
0.4670
-30.32%